openPR Logo
Press release

United States Ursodeoxycholic Acid Market by Manufacturers, States, Type and Application, Forecast to 2022

07-25-2017 09:14 AM CET | Health & Medicine

Press release from: ReportsWorldwide

United States Ursodeoxycholic Acid Market by Manufacturers,

ReportsWorldwide has announced the addition of a new report title United States Ursodeoxycholic Acid Market by Manufacturers, States, Type and Application, Forecast to 2022 to its growing collection of premium market research reports.

Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3α, 7β-2-hydroxy-5β-bile acid, UDCA) was first found in the bile of a black bear.
Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis.
In this report, the Ursodeoxycholic Acid mentioned is Ursodeoxycholic Acid API. And the CAS number is 128-13-2.

Scope of the Report:

This report focuses on the Ursodeoxycholic Acid in United States market, to split the market based on manufacturers, states, type and application.

To view a detailed description and Table of Contents please visit: https://www.reportsworldwide.com/report/united-states-ursodeoxycholic-acid-market-by-manufacturers-states-type-and-application-forecast-to-2022

Market Segment by Manufacturers, this report covers

• ICE
• Grindeks
• Mitsubishi
• Daewoong chemical
• PharmaZell GmbH
• Dipharma Francis
• Zhangshanbelling
• Erregierre
• Abil Chempharma
• Biotavia Labs
• Suzhou Tianlu
• Arcelor Chemicals

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Market Segment by Type, covers

• Synthetic Ursodeoxycholic Acid
• Extraction Ursodeoxycholic Acid

Market Segment by Applications, can be divided into

• Pharmacy
• Health Products

To Get Sample Copy of Report please visit @ https://www.reportsworldwide.com/enquiry?report_id=39931

About ReportsWorldwide.com

ReportsWorldwide.com is a leading provider of global market intelligence reports and services. With research reports from top publishers, consulting and advisory firms, ReportsWorldwide.com offers instant online access to a growing database of expert insights on global industries, companies, products, geographies and trends.

Press Contact:

Abigail Crasto
Senior Vice President
101, Arch Street
Boston, MA 02110
US
Phone +1 (617) 398-4994
Fax +1 (617) 398-4995
abigail@reportsworldwide.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release United States Ursodeoxycholic Acid Market by Manufacturers, States, Type and Application, Forecast to 2022 here

News-ID: 639167 • Views:

More Releases from ReportsWorldwide

World Deep Brain Stimulation Market Top Segments, Key Players Revenue, Growth Ra …
The World Deep Brain Stimulation Market is estimated to represent a global market of USD 751.8 million by 2017 with growth rate of 18.2%. Deep brain stimulation (DBS) procedure is primarily used for the treatment of neuropsychiatric disorders such as mood disorder, dementia, anxiety and others. The procedure involve the use of neurotransmitter (brain pacemaker) that enables to transmit electric impulses to the specific target of brain cells. Increasing incidence
New report explores the Gene Editing Market : Ushering The Next Breakthrough in Regenerative Medicine
New report explores the Gene Editing Market : Ushering The Next Breakthrough in …
Boston, MA ReportsWorldwide has announced the addition of a new report title Gene Editing The Next Breakthrough in Regenerative Medicine to its growing collection of premium market research reports. Genome editing is a type of genetic engineering in which DNA is replaced, inserted or deleted in a living organism's ggenome using engineered molecular scissors. Believed to be one of the great biotechnology breakthroughs, gene editing is a powerful tool in pharmaceutical research that
Global In-Building Wireless BTSController-based Small Cells Market Analysis and Forecast, 2017-2021
Global In-Building Wireless BTSController-based Small Cells Market Analysis and …
Boston, MA ReportsWorldwide has announced the addition of a new report title Global In-Building Wireless BTSController-based Small Cells Market Analysis and Forecast, 2017-2021 to its growing collection of premium market research reports. This report covers the leading in-building wireless enterprise BTS/controller-based small cells network equipment manufacturers: • CommScope/Airvana • Comba Telecom • Ericsson • Huawei Technologies • Nokia • SpiderCloud • ZTE Corporation This report covers the global market share for 2016 shipments as well as a forecast for 2017-2021. To view a detailed description and Table of

More Releases for Ursodeoxycholic

Ursodeoxycholic Acid API Market Size, Share, Development by 2025
LP INFORMATION recently released a research report on the Ursodeoxycholic Acid API analysis, which studies the Electrical Cord Reels's industry coverage, current market competitive status, and market outlook and forecast by 2025. Global “Ursodeoxycholic Acid API 2020-2025” Research Report categorizes the global Ursodeoxycholic Acid API by key players, product type, applications and regions,etc. The report also covers the latest industry data, key players analysis, market share,
Ursodeoxycholic Acid Market Trends and Dynamic 2025 | Arcelor Chemicals
Global Ursodeoxycholic Acid Market: Overview Ursodeoxycholic acid (UDCA) is essentially bile acid ingested in the liquid form or in the form of a tablet to cure gallstones. Those can cure or thwart the progress of cystic fibrosis-related liver disorder. UDCA transforms the bile acid pool by lowering the levels of hydrophobic bile acids. This increases the amount of nontoxic hydrophilic bile acids. Besides, UDCA can slow down the development of gastroesophageal
Global Ursodeoxycholic Acid Industry Market Analysis & Forecast 2018-2023
Global Ursodeoxycholic Acid Industry has been utilized in the administration of puppies with incessant hepatitis and felines with lymphocytic plasmacytic cholangitis. It is accepted to be most useful in scatters where bile poisonous quality assumes an imperative job in the continuous pathology. The adequacy of Global Ursodeoxycholic Acid Industry in veterinary patients has not been certainly settled, in spite of the fact that reports recommend it might have some advantage
Ursodeoxycholic Acid Market 2017-ICE, Grindeks, Mitsubishi Tanabe, Daewoong chem …
Apex Market Reports, recently published a detailed market research study focused on the "Ursodeoxycholic Acid Market" across the global, regional and country level. The report provides 360° analysis of "Ursodeoxycholic Acid Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Ursodeoxycholic Acid industry, and estimates the future trend of Ursodeoxycholic Acid market
Ursodeoxycholic Acid Market 2017 Forecast to 2022
"Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3α, 7β-2-hydroxy-5β-bile acid, UDCA) was first found in the bile of a black bear. Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis." Read Detailed Full Report @ https://www.reportsandmarkets.com/reports/global-north-america-europe-and-asia-to-2022-1686998 Scope of the Report: Ursodeoxycholic Acid in Global market, especially in North
Ursodeoxycholic Acid Market- ICE, Grindeks, Mitsubishi, Daewoong chemical, Pharm …
Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3a, 7ß-2-hydroxy-5ß-bile acid, UDCA) was first found in the bile of a black bear. Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis. In this report, the Ursodeoxycholic Acid we mentioned is Ursodeoxycholic Acid API. And the CAS number